Discussion by rheumatologists on the merits of biologics vs. triple therapy for patients with RA lends insight into therapeutic alternatives
Search results for: etanercept
2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review
Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology
Doest Rheumatoid Arthritis Take a Toll?
Exploring the Toll background
Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors
Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
EULAR 2013: Drugs New and Old Could Treat Spondylarthropies
Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored
When Will Generic Biologic Drugs Become Commercially Available?
Biosimilars are challenging to produce, but progress is being made
ACR 2013 State-of-the-Art Clinical Symposium: The Challenge of Treating Low Back Pain
With no single therapy effective for chronic low back pain, physicians must try multiple therapeutic approaches, nonsurgical options
ACR 2013 State-of-the-Art Clinical Symposium: What’s Next in Therapy for Osteoarthritis, Rheumatoid Arthritis, and Lupus?
Experts highlight treatment advances and challenges ahead in OA, RA, and systemic lupus erythematosus (SLE)
ACR 2013 State-of-the-Art Clinical Symposium: Diagnosis and Management of Vasculitis
The latest on Behçet’s syndrome, infectious arthritis, and central nervous system vasculitis
- « Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 30
- Next Page »